Johnson & Johnson predicts 4% to 6% net price decline in pharma this year, with Remicade down by double digits in Q2
admin 17th July 2018 Uncategorised 0Amid an industrywide debate over drug prices, top player Johnson & Johnson reports its net prices will fall between 4% and 6% in 2018.
More: Johnson & Johnson predicts 4% to 6% net price decline in pharma this year, with Remicade down by double digits in Q2
Source: fierce